Leading Pharmaceutical Operational Excellence Outstanding Practices and Cases /

Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Friedli, Thomas. (Editor), Basu, Prabir. (Editor), Bellm, Daniel. (Editor), Werani, Jürgen. (Editor)
Format: Electronic
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2013.
Subjects:
Online Access:View fulltext via EzAccess
LEADER 02669nam a22005535i 4500
001 24184
003 DE-He213
005 20151204144814.0
007 cr nn 008mamaa
008 131126s2013 gw | s |||| 0|eng d
020 # # |a 9783642351617  |9 978-3-642-35161-7 
024 7 # |a 10.1007/978-3-642-35161-7  |2 doi 
050 # 4 |a TS155-TS194 
072 # 7 |a KJMV  |2 bicssc 
072 # 7 |a BUS087000  |2 bisacsh 
082 0 4 |a 658.5  |2 23 
245 1 0 |a Leading Pharmaceutical Operational Excellence  |b Outstanding Practices and Cases /  |c edited by Thomas Friedli, Prabir Basu, Daniel Bellm, Jürgen Werani.  |h [electronic resource] : 
264 # 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2013. 
300 # # |a IX, 541 p. 263 illus.  |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
505 0 # |a Part A - Introduction -- Part B - Leading Operational Excellence - Outstanding Practices -- Part C - Leading Operational Excellence - Outstanding Leadership -- Part D - Gaining the Future. 
520 # # |a Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies. 
650 # 0 |a Business. 
650 # 0 |a Management. 
650 # 0 |a Leadership. 
650 # 0 |a Production management. 
650 # 0 |a Operations research. 
650 # 0 |a Decision making. 
650 # 0 |a Pharmaceutical technology. 
650 1 4 |a Business and Management. 
650 2 4 |a Operations Management. 
650 2 4 |a Business Strategy/Leadership. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Operation Research/Decision Theory. 
650 2 4 |a Management. 
700 1 # |a Friedli, Thomas.  |e editor. 
700 1 # |a Basu, Prabir.  |e editor. 
700 1 # |a Bellm, Daniel.  |e editor. 
700 1 # |a Werani, Jürgen.  |e editor. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642351600 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-642-35161-7  |z View fulltext via EzAccess 
912 # # |a ZDB-2-SBE 
950 # # |a Business and Economics (Springer-11643)